Moderna, Inc. Revenue 2016–2025
Moderna, Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Moderna, Inc. revenue for the quarter ending March 31, 2026 was 389.0 M, a 260.19% increase year-over-year.
- Moderna, Inc. revenue for the twelve months ending March 31, 2026 was 1.7 B, a 59.64% decrease year-over-year.
- Moderna, Inc. annual revenue for 2025 was 1.9 B, a 39.93% decrease from 2024.
- Moderna, Inc. annual revenue for 2024 was 3.2 B, a 52.75% decrease from 2023.
- Moderna, Inc. annual revenue for 2023 was 6.8 B, a 64.45% decrease from 2022.
- Moderna, Inc. annual revenue for 2022 was 19.3 B.
Moderna Inc. (MRNA) — Frequently Asked Questions
Moderna Inc. (MRNA) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $17.89B. In fiscal 2025 it reported revenue of $1.94B and net income of -$2.82B. Explore MRNA's stock price, financial statements, earnings history, margins and key ratios below.
What is Moderna Inc.'s market cap?
Moderna Inc. (MRNA) has a market capitalization of $17.89B.
What is the MRNA stock price?
MRNA trades at $45.99 (-3.65% on the day).
How much revenue does Moderna Inc. make?
Moderna Inc. reported revenue of $1.94B in fiscal 2025.
Is MRNA profitable?
In fiscal 2025, Moderna Inc. reported net income of -$2.82B.